Copyright © 2000 by the European Society of Cardiology.
C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris
a Herz- und Gefäßklinik, Bad Neustadt/Saale, Germany
b Städtisches Klinikum, Solingen, Germany
c Institut für Arterioskleroseforschung an der Universität Münster, Germany
d Institut für Klinische Chemie und Laboratoriumsmedizin, Universität Münster, Germany
e Klinikum Meiningen, Meiningen, Germany
revised October 12, 1999; accepted October 13, 1999
Abstract
Background Recent findings provide evidence for the importance of inflammatory processes in the pathogenesis of atherosclerosis. C-reactive protein was elevated in patients with peripheral artery disease, coronary heart disease and myocardial infarction compared to normal subjects.
Methods In 1112 male and 299 female survivors of myocardial infarction (mean age±SD, men, 50·4±9·5, women, 56·1±9·3), we investigated whether plasma C-reactive protein concentration is associated with the severity of coronary heart disease and generalized pre-clinical or clinically manifest arteriopathy. The control group consisted of 326 male and 138 female individuals matched for age without clinical symptoms of coronary disease. The severity of arteriosclerotic changes was determined for the extra-cranial brain-supplying arteries, abdominal aorta, pelvis and leg arteries. In myocardial infarction patients coronary angiography was performed. Laboratory analyses included determination of C-reactive protein, fibrinogen, D-dimer, HDL-cholesterol, LDL-cholesterol and triglycerides.
Results The following ranking of C-reactive protein concentrations was found: controls
patients after myocardial infarction without atherosclerosispatients with myocardial infarction and pre-clinical atherosclerosispatients with myocardial infarction and clinically manifest atherosclerosis. Additionally, our data showed a significant association between C-reactive protein concentrations and the angiographically detected degree of coronary heart disease.
Conclusions As C-reactive protein is a marker of inflammatory processes, our results in patients with clinically manifest and early pre-clinical atherosclerosis support the hypothesis that inflammatory processes in the vessel wall participate in atherogenesis. Moreover, they support the hypothesis of a causal relationship between an acute phase reaction and the pathogenesis of atherosclerosis in coronary arteries and other parts of the arterial vessel system.
Key Words: C-reactive protein, coronary disease, myocardial infarction, atherosclerosis, risk factors
f1 Correspondence: Dr med Mira-Christine Tataru, Herz- und Gefäßklinik, Salzburger Leite 1, D-97161 Bad Neustadt, Germany
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Gimelli, G. Rossi, P. Landi, P. Marzullo, G. Iervasi, A. L'Abbate, and D. Rovai Stress/Rest Myocardial Perfusion Abnormalities by Gated SPECT: Still the Best Predictor of Cardiac Events in Stable Ischemic Heart Disease J. Nucl. Med., April 1, 2009; 50(4): 546 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Rosvall, G Engstrom, L Janzon, G Berglund, and B Hedblad The role of low grade inflammation as measured by C-reactive protein levels in the explanation of socioeconomic differences in carotid atherosclerosis Eur J Public Health, August 1, 2007; 17(4): 340 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Oren, A. R. Erbay, M. Balci, and S. Cehreli Role of Novel Biomarkers of Inflammation in Patients With Stable Coronary Heart Disease Angiology, April 1, 2007; 58(2): 148 - 155. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Lenderink, C. Heeschen, S. Fichtlscherer, S. Dimmeler, C. W. Hamm, A. M. Zeiher, M. L. Simoons, E. Boersma, and for the CAPTURE Investigators Elevated Placental Growth Factor Levels Are Associated With Adverse Outcomes at Four-Year Follow-Up in Patients With Acute Coronary Syndromes J. Am. Coll. Cardiol., January 17, 2006; 47(2): 307 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cosin-Sales, J. C. Kaski, M. Christiansen, P. Kaminski, C. Oxvig, M. T. Overgaard, D. Cole, and D. W. Holt Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris Eur. Heart J., October 2, 2005; 26(20): 2093 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Arroyo-Espliguero, P. Avanzas, J. Cosin-Sales, G. Aldama, C. Pizzi, and J. C. Kaski C-reactive protein elevation and disease activity in patients with coronary artery disease Eur. Heart J., March 1, 2004; 25(5): 401 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Silvestro, F. Scopacasa, A. Ruocco, G. Oliva, V. Schiano, C. Zincarelli, and G. Brevetti Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease Vascular Medicine, November 1, 2003; 8(4): 225 - 232. [Abstract] [PDF]
|
|
|
|
 |
|
 T. A. Pearson, G. A. Mensah, R. W. Alexander, J. L. Anderson, R. O. Cannon III, M. Criqui, Y. Y. Fadl, S. P. Fortmann, Y. Hong, G. L. Myers, et al. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association Circulation, January 28, 2003; 107(3): 499 - 511. [Full Text] [PDF]
|
|
|
|
|
|
T Lenderink, E Boersma, C Heeschen, A Vahanian, M.-J de Boer, V Umans, M.J.B.M van den Brand, C.W Hamm, M.L Simoons, and for the CAPTURE investigators Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA Eur. Heart J., January 1, 2003; 24(1): 77 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Stangl, G. Baumann, and K. Stangl Coronary atherogenic risk factors in women Eur. Heart J., November 2, 2002; 23(22): 1738 - 1752. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Zebrack, J. B. Muhlestein, B. D. Horne, J. L. Anderson, and Intermountain Heart Collaboration Study Group C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina J. Am. Coll. Cardiol., February 20, 2002; 39(4): 632 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Singh, S. Hsia, P. Alaupovic, I. Sinha-Hikim, L. Woodhouse, T. A. Buchanan, R. Shen, R. Bross, N. Berman, and S. Bhasin The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young Men J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 136 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Blackburn, P. Giral, E. Bruckert, J.-M. Andre, S. Gonbert, M. Bernard, M. J. Chapman, and G. Turpin Elevated C-Reactive Protein Constitutes an Independent Predictor of Advanced Carotid Plaques in Dyslipidemic Subjects Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1962 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Monaco, F. Crea, G. Niccoli, F. Summaria, D. Cianflone, R. Bordone, G. Bellomo, and A. Maseri Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications Eur. Heart J., September 1, 2001; 22(17): 1572 - 1577. [Abstract] [PDF]
|
|
|
|
|
|
P.J.M. Best and B.J. Gersh Cell adhesion molecules and inflammation in acute coronary syndromes: markers and emerging risk factors Eur. Heart J., July 2, 2001; 22(14): 1155 - 1159. [PDF]
|
|
|
|
|
|
P. Bogaty, P. Poirier, S. Simard, L. Boyer, S. Solymoss, and G. R. Dagenais Biological Profiles in Subjects With Recurrent Acute Coronary Events Compared With Subjects With Long-Standing Stable Angina Circulation, June 26, 2001; 103(25): 3062 - 3068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Williams and P. F. Bray Genetics of Arterial Prothrombotic Risk States Experimental Biology and Medicine, May 1, 2001; 226(5): 409 - 419. [Abstract] [Full Text]
|
|
|
|
|
|
W.S. Weintraub and D.G. Harrison C-reactive protein, inflammation and atherosclerosis: do we really understand it yet? Eur. Heart J., June 2, 2000; 21(12): 958 - 960. [PDF]
|
|